Biolog

What Biolog does

Biolog is a privately held biotechnology company founded in 1983 and headquartered in Hayward, California, with a second lab services facility in Newark, Delaware. The company specializes in microbial identification and cellular phenotypic characterization, serving pharmaceutical, food and beverage, industrial/bioprocessing, agricultural, and academic research customers across roughly five primary verticals. Its proprietary platform is built on patented redox tetrazolium dye chemistry that produces colorimetric metabolic fingerprints, read by two instrument families — the high-throughput Odin (Odin L and Odin VIII) and the semi-automated ID Station — and matched against a curated database of nearly 3,000 organisms for species-level identification of bacteria, yeast, and filamentous fungi.

The company generates revenue through three interlocking streams: capital equipment sales (Odin instruments, ID Station, and AS-500/AS-150 anaerobic chambers using InstaSleeve gloveless technology), recurring consumables (Phenotype MicroArrays, GEN III/YT/FF/AN identification panels, EcoPlate, RhizoPlates, PreBioM, Anaerobic MediaMatcher, Biolog Synthetic Media, TruPRAS media, and MycoPM plates), and fee-for-service lab testing at two ISO 17025-accredited facilities with 3-day standard turnaround. Pricing is quote-based for instruments, chambers, and custom media, while lab services use pay-as-you-go with bulk and standing order discounts. Distribution combines direct enterprise sales, an international distributor network, an online quote-request channel for SMBs, and a dedicated lab services portal.

Biolog has pursued a deliberate roll-up strategy, completing the acquisition of MIDI Inc. in January 2023 and Anaerobe Systems in February 2025, alongside two SEC Form D exempt securities offerings totaling approximately $34 million. The platform holds an unusually broad regulatory footprint — ISO 17025:2017 accreditation, FDA and GDUFA registration, AOAC and AFNOR validated methods, USDA/APHIS permits, and an EU IVDR CE mark on Anaerobe Systems media — positioning the company as a compliance-anchored incumbent across research, QC, food safety, and now clinical diagnostics end markets.

Name

Biolog

Legal name

Biolog, Inc.

Website

https://biolog.com

Company type

Private

Founded year

1983

Operating status

Operating

Headcount range

51–100 employees

Short description

Biolog is a 40+ year privately held biotechnology company that provides microbial identification and cellular phenotypic characterization instruments, consumables, and lab services to pharmaceutical, food and beverage, industrial, agricultural, and academic customers using proprietary redox dye chemistry and a 3,000-organism identification database.

Ownership category

akta.pro rank

Product category

Microbiology Instruments and Consumables

NAICS

Analytical Laboratory Instrument Manufacturing (334516), Medical and Diagnostic Laboratories (6215), Medical Laboratories (621511), Research and Development in Biotechnology (except Nanobiotechnology) (541714)

SIC

Services-Medical Laboratories (8071), Laboratory Analytical Instruments (3826), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Microbiology & Infectious Disease Diagnostics (culture, rapid antigen, syndromic panels) (HLAAALAC)

akta.pro secondary industries

Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE), Microbiome & Metagenomics Services (HLAGANAH), Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD)

Keywords

• Microbial identification instruments
• Phenotypic microplate assays
• Anaerobic culture systems
• Cellular metabolism analysis
• Microbiology lab services

Headquarters

HQ city

Hayward

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Instrument Sales: Sale of Odin instruments (Odin L, Odin VIII) and ID Station systems - capital equipment purchases for labs performing microbial identification and phenotypic analysis.
2. Consumables and Microplates: Recurring revenue from Phenotype MicroArrays, microbial identification microplates (GEN III, YT, FF, AN), community analysis plates (EcoPlate, RhizoPlates, PreBioM), and reagents.
3. Lab Services: Fee-for-service testing including microbial identification (DNA sequencing, MALDI-TOF, phenotypic), enumeration, USP <797> testing, phenotypic profiling, water testing, and foodborne pathogen testing.
4. Anaerobic Media and Chambers: Sales of TruPRAS anaerobic culture media, anaerobic chambers, and related accessories for microbiology labs working with oxygen-sensitive organisms.
5. Custom Media Manufacturing: Bespoke media formulation and manufacturing services for specialized culturing requirements.

Pricing tiers

Go-to-market motion2 records

Distribution channels4 records

Marketing channels7 records

Core offering

Biolog designs, manufactures, and sells instruments (Odin family, ID Station), proprietary 96-well microplates, anaerobic chambers, and culture media used for microbial identification and cellular phenotype characterization. The company also operates two US-based laboratories that provide fee-for-service microbial identification, enumeration, USP <797>, foodborne pathogen, and water testing to pharmaceutical, food & beverage, industrial, agricultural, and academic customers.

Product overview

Biolog is a biotechnology company offering an integrated platform for microbial identification and cellular phenotypic characterization. The portfolio centers on two instrument families (Odin and ID Station) that read proprietary 96-well microplates containing biochemical substrates and redox dyes to generate phenotypic fingerprints. Core consumable lines include Phenotype MicroArrays (PM series for microbial, mammalian, and mitochondrial phenotypes), Microbial Identification panels (GEN III, YT, FF, AN), and Community Analysis plates (EcoPlate, RhizoPlates, PreBioM). The company operates two lab services divisions (East in Newark DE, West in Hayward CA) providing outsourced testing using the same proprietary technology. Acquired brands include Anaerobe Systems (TruPRAS media) and MIDI Inc. (microbial identification).

Differentiator

Problem solved

Functional benefit

Brands

• TruPRAS: TruPRAS media brand for pre-reduced, anaerobically sterilized culture media manufactured and packaged under oxygen-free conditions.
• Odin
• ID Station
• PreBioM
• RhizoPlates
• MycoPM
• MediaMatcher

Products and services

• Odin Family (Odin L & Odin VIII) All-in-one automated incubator and reader instruments that measure cellular metabolic respiration and optical density across up to 50 plates (Odin L) or 8 plates (Odin VIII), generating kinetic data every 2-20 minutes for microbial identification and phenotype characterization. Targeted at microbiology, pharmaceutical, and academic labs.
• ID Station Semi-automated single-plate reader for identifying bacteria, yeast, and filamentous fungi by matching metabolic fingerprints against Biolog's database of nearly 3,000 organisms. Used by clinical, food safety, and research microbiology labs.
• Anaerobic Chambers (AS-500 & AS-150) Oxygen-free work chambers for cultivating obligate and facultative anaerobes, available in 500-plate (AS-500) and 144-plate (AS-150) capacities, featuring InstaSleeve gloveless access technology for dexterity without compromising the anaerobic environment.
• Microbial Phenotype MicroArrays (PM 1-25)
• MycoPM Plate Series (Ionotox, Permeatox, Genotox) Three 96-well microplates containing 45 compounds across six concentration gradients, designed for phenotypic profiling and inhibitory compound testing of yeast and filamentous fungi. Targets antifungal drug discovery and mycological research.
• Mammalian Phenotype MicroArrays (PM-M Series)
• MitoPlate Phenotype

Quantifiable outcome

• Identify microorganisms in as little as 1 hour
• +3 more outcomes

Named customers5 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature10 records

Partnerships

Two partnerships are on record, tiered core.

• Anaerobe SystemscoreStrategic or Co-development Partner · 12 February 2025Biolog acquired Anaerobe Systems as its third acquisition, marking a significant step toward establishing Biolog as the knowledge leader in microbiology research and clinical sample preparation. Anaerobe Systems brings specialized anaerobic culture media (TruPRAS) and anaerobic chamber products.
• MIDI Inc.coreStrategic or Co-development Partner · 1 January 2023Biolog acquired MIDI Inc., a firm specializing in microbial identification and analysis, for an undisclosed sum in January 2023. The acquisition expanded Biolog's portfolio to offer comprehensive microbial profiling solutions and strengthened their position in the microbial identification market.

Scale indicators7 records

Recent moves6 records

Expansion highlights5 records

Others

• Thermo Fisher Scientific:

Emerging players

• QIAGEN: Provider of molecular sample preparation and microbial detection PCR assays for food safety, veterinary, and clinical diagnostics. Indirect overlap with Biolog's microbial ID and foodborne pathogen testing businesses via molecular alternatives.
• Accelerate Diagnostics: Developer of rapid antimicrobial susceptibility testing platforms (Pheno system) for clinical microbiology labs. Direct comparable as a phenotypic microbiology player competing on time-to-result versus Biolog's Odin and ID Station.

Direct peers

• bioMérieux: Global leader in in vitro diagnostics and microbiological testing, with the VITEK and API product lines for microbial identification and antimicrobial susceptibility testing. Directly competes with Biolog in phenotypic microbial ID across clinical, food, and pharmaceutical markets.
• Hardy Diagnostics: Specialty microbiology supplies and contract manufacturing company offering culture media, chromogenic agars, and identification products to clinical and industrial labs. Direct comparable as a mid-sized U.S. specialty microbiology provider with overlapping product categories.
• Bruker Corporation: Operates the MALDI Biotyper platform for microbial identification using mass spectrometry, the dominant proteotypic alternative to Biolog's phenotypic approach. Also offers molecular diagnostics, directly competing in the multiomic microbial ID services market.
• Eurofins Scientific: Global leader in food, environmental, pharmaceutical, and clinical testing services, including microbiology and sterility testing. Directly comparable lab services competitor to Biolog Lab Services across USP <797>, foodborne pathogen, and water testing.
• Don Whitley Scientific: UK-based manufacturer of anaerobic workstations and microbiology equipment, directly competing with Biolog's AS-500 and AS-150 anaerobic chambers in European and global research and clinical labs.

Broad incumbents

• Becton, Dickinson and Company (BD): Global medical technology company with the BD Phoenix M50 and BD MAX systems for automated microbial identification and molecular diagnostics. Broad incumbent serving the same clinical microbiology customers as Biolog with a wider portfolio.
• Charles River Laboratories: Provides microbial identification, endotoxin, and sterility testing services to pharmaceutical and biotech customers under its Manufacturing Solutions segment. Competes with Biolog Lab Services in regulated pharmaceutical and bioprocessing testing.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xtwitter.com/BiologInc
• Facebookfacebook.com/biologcompany
• LinkedInlinkedin.com/company/biolog-inc.

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries2 records

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biolog